Effective treatment of low risk acute GVHD with itacitinib monotherapy
Original Publication Date
Article Source
External Web Content
Key Points Itacitinib monotherapy is as effective as systemic corticosteroids for the treatment of low risk acute GVHD. Itacitinib monotherapy resulted in fewer serious infections compared to systemic corticosteroids. The standard primary treatment for acute graft vs host disease…
